Redston Mitchell R, Hilmer Sarah N, McLachlan Andrew J, Clough Alexander J, Gnjidic Danijela
Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Departments of Aged Care and Clinical Pharmacology, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, NSW, Australia.
J Alzheimers Dis. 2018;61(4):1639-1652. doi: 10.3233/JAD-170842.
Older people with cognitive impairment, including dementia and delirium, are high users of acute care services internationally. Potentially inappropriate medication (PIM) use may be associated with adverse outcomes, including hospital re-admission, functional disability, and mortality.
This systematic review aimed to quantify and compare the prevalence of PIMs in older inpatients with and without cognitive impairment.
A systematic search of observational studies was performed independently assessed by two reviewers in Embase, Medline, PsycINFO, International Pharmaceutical Abstracts, Scopus, and Informit. Articles published in English during the period January 2007-June 2017 that reported PIM prevalence in hospital inpatients ≥ 65 years were included. PIMs were defined as the presence of polypharmacy (multiple medication use) and using implicit or explicit tools, such as the Beers criteria, and 'Screening Tool of Older Person's Prescriptions' (STOPP).
47 articles were included. In studies measuring polypharmacy (n = 15), the prevalence of PIMs ranged from 53.2% to 89.8% and 30.4% to 97.1% for inpatients with and without cognitive impairment, respectively, and 24.0% to 80.0% when cognitive status was unreported. In studies employing explicit and implicit tools (n = 35), the prevalence of PIMs when cognitive impairment was reported ranged from 20.6% to 80.5% using the Beers criteria, and 39.3% to 88.5% using STOPP. When cognitive status was unreported, the prevalence of PIMs ranged from 7.0% to 79.2% using the Beers criteria, and 20.0% to 63.4% using STOPP.
Our findings suggest a high prevalence of PIMs in older inpatients with and without cognitive impairment. Future studies should investigate the impact of PIM use on patient-centered outcomes, such as functional status and quality of life, to inform enhanced acute care services.
在国际上,患有认知障碍(包括痴呆和谵妄)的老年人是急性护理服务的高使用者。潜在不适当用药(PIM)可能与不良后果相关,包括再次住院、功能残疾和死亡。
本系统评价旨在量化并比较有认知障碍和无认知障碍的老年住院患者中PIM的患病率。
两名评价者独立对Embase、Medline、PsycINFO、国际药学文摘、Scopus和Informit进行系统检索,纳入2007年1月至2017年6月期间发表的英文文章,这些文章报告了≥65岁住院患者的PIM患病率。PIM被定义为存在多重用药(使用多种药物),并使用如Beers标准和“老年人处方筛查工具”(STOPP)等隐性或显性工具。
纳入47篇文章。在测量多重用药的研究(n = 15)中,有认知障碍和无认知障碍的住院患者中PIM的患病率分别为53.2%至89.8%和30.4%至97.1%,未报告认知状态时为24.0%至80.0%。在使用显性和隐性工具的研究(n = 35)中,报告有认知障碍时使用Beers标准的PIM患病率为20.6%至80.5%,使用STOPP时为39.3%至88.5%。未报告认知状态时,使用Beers标准的PIM患病率为7.0%至79.2%,使用STOPP时为20.0%至63.4%。
我们的研究结果表明,有认知障碍和无认知障碍的老年住院患者中PIM的患病率都很高。未来的研究应调查PIM使用对以患者为中心的结局(如功能状态和生活质量)的影响,以为改善急性护理服务提供依据。